• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平血清浓度;对血压正常志愿者血压和心率的影响。

Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.

作者信息

Nakashima T, Inoki M, Nakanishi Y

出版信息

Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):73-8. doi: 10.1007/BF03189607.

DOI:10.1007/BF03189607
PMID:6714271
Abstract

Nifedipine (10 mg) was administered orally to 8 normotensive volunteers. Various measurements such as concentration in serum, blood pressure, and heart rate, were made at 0, 20', 40', 1, 2, 3, 4, 6, 8 and 24 h after administration. The sample serum, internal standard (diethyl 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate), HCl and NaNO2 were allowed to react and GLC-ECD was carried out after extration with organic solvent. The retention time was 3 min for nifedipine and 4 min for internal standard. Absorption curves were classified into 3 types: a rapid absorption rate (2 subjects) in which the maximum measured nifedipine concentration (70-80 ng/ml) was obtained, within 20-40 min after administration, a slower absorption rate (3 subjects) and an intermediate absorption rate (3 subjects) and an intermediate absorption rate (3 subjects). A decrease in systolic blood pressure was observed, but no significant difference in diastolic blood pressure and heart rate could be noted among the volunteers.

摘要

给8名血压正常的志愿者口服硝苯地平(10毫克)。在给药后0、20分钟、40分钟、1小时、2小时、3小时、4小时、6小时、8小时和24小时进行了各种测量,如血清浓度、血压和心率。使样本血清、内标(2,6-二甲基-4-(2-硝基苯基)-3,5-吡啶二羧酸二乙酯)、盐酸和亚硝酸钠反应,并在用有机溶剂萃取后进行气相色谱-电子捕获检测。硝苯地平的保留时间为3分钟,内标的保留时间为4分钟。吸收曲线分为3种类型:快速吸收型(2名受试者),给药后20 - 40分钟内测得硝苯地平最大浓度(70 - 80纳克/毫升);吸收较慢型(3名受试者);吸收中间型(3名受试者)。观察到收缩压下降,但志愿者之间舒张压和心率无显著差异。

相似文献

1
Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.硝苯地平血清浓度;对血压正常志愿者血压和心率的影响。
Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):73-8. doi: 10.1007/BF03189607.
2
Effect of food ingestion on nifedipine absorption and haemodynamic response.食物摄入对硝苯地平吸收及血流动力学反应的影响。
Eur J Clin Pharmacol. 1985;28(1):105-7. doi: 10.1007/BF00635716.
3
Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system.使用渗透系统直肠输注硝苯地平至稳态时的动力学和动态变化。
Clin Pharmacol Ther. 1984 Sep;36(3):396-401. doi: 10.1038/clpt.1984.194.
4
Serum levels and possible haemodynamic effects following anorectal application of an ointment containing nifedipine and lignocaine : a study in healthy volunteers.含硝苯地平和利多卡因的软膏经肛门直肠给药后的血清水平及可能的血流动力学效应:一项在健康志愿者中的研究
Clin Drug Investig. 2006;26(8):459-67. doi: 10.2165/00044011-200626080-00004.
5
Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state.硝苯地平在稳态患者中的药代动力学和药效学。
J Clin Pharmacol. 1986 Nov-Dec;26(8):587-92. doi: 10.1002/j.1552-4604.1986.tb02954.x.
6
Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects.正常受试者舌下含服硝苯地平后血浆水平与心血管效应的相关性。
J Clin Pharmacol. 1985 Mar;25(2):125-9. doi: 10.1002/j.1552-4604.1985.tb02812.x.
7
Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives.硝苯地平直肠给药:高血压患者的血流动力学效应和药代动力学
J Int Med Res. 1987 May-Jun;15(3):121-7. doi: 10.1177/030006058701500301.
8
[Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].硝苯地平两种口服制剂的临床及药代动力学比较:10毫克胶囊与20毫克缓释片
Arch Inst Cardiol Mex. 1989 Jan-Feb;59(1):73-80.
9
[Effects of a calcium antagonist (nifedipine) in hypertensive and normotensive subjects].[钙拮抗剂(硝苯地平)对高血压和血压正常受试者的影响]
Arch Inst Cardiol Mex. 1988 Mar-Apr;58(2):137-43.
10
Serum concentrations and effects of (+/-)-nicardipine compared with nifedipine in a population of healthy subjects.在健康受试者群体中,(±)-尼卡地平与硝苯地平的血清浓度及效应比较。
Clin Pharmacol Ther. 1990 Aug;48(2):155-60. doi: 10.1038/clpt.1990.130.

引用本文的文献

1
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.硝苯地平。对其在缺血性心脏病、高血压及相关心血管疾病中的药效学、药代动力学特性及治疗效果的综述。
Drugs. 1985 Sep;30(3):182-274. doi: 10.2165/00003495-198530030-00002.

本文引用的文献

1
Per cent absorbed time plots derived from blood level and/or urinary excretion data.根据血药浓度和/或尿排泄数据得出的吸收百分比-时间曲线图。
J Pharm Sci. 1963 Jun;52:610-1. doi: 10.1002/jps.2600520629.
2
Identification of nifedipine metabolites and their determination by gas chromatography.
Chem Pharm Bull (Tokyo). 1980 Jan;28(1):1-7. doi: 10.1248/cpb.28.1.
3
Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.
Eur J Clin Pharmacol. 1980;17(3):161-4. doi: 10.1007/BF00561894.
4
Comparison of acute effects of nifedipine in normotensive and hypertensive man.
J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):357-66. doi: 10.1097/00005344-198007000-00003.
5
[Dihydropyridines, a new group of strongly effective coronary therapeutic agents].[二氢吡啶类,一类新型强效冠状动脉治疗药物]
Naturwissenschaften. 1971 Nov;58(11):578. doi: 10.1007/BF00598745.
6
[Clinical study on the pharmacokinetics of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].[放射性标记的4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯的药代动力学临床研究]
Arzneimittelforschung. 1972 Feb;22(2):330-4.
7
[Fluorometric determination of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester and its main metabolite].[4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯及其主要代谢产物的荧光测定法]
Arzneimittelforschung. 1972 Jan;22(1):60-2.
8
[Structural analysis of the renal excretion products of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].[4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯的肾脏排泄产物的结构分析]
Arzneimittelforschung. 1972 Jan;22(1):53-6.
9
[Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].[放射性标记的4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯的药代动力学和生物转化的动物实验]
Arzneimittelforschung. 1972 Jan;22(1):42-53.
10
[Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯(硝苯地平,BAY a 1040)的药理学
Arzneimittelforschung. 1972 Jan;22(1):1-14.